Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Tanner

Showing results (421-430 of 424) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 424 results.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Lancet (London, England)|September 15, 2015
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Mohammad H Forouzanfar, Lily Alexander, et al.
Pageof 43

Showing results (421-430 of 424) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 424 results.
The New England Journal of Medicine|October 20, 2011
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children, Selidji Todagbe Agnandji, Bertrand Lell, et al.
The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.
Lancet (London, England)|September 1, 2015
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition, Christopher J L Murray, Ryan M Barber, et al.
Lancet (London, England)|September 15, 2015
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Mohammad H Forouzanfar, Lily Alexander, et al.
Pageof 43